Programs
4 pages in this section, most recently updated September 4, 2026.
- 01
LillyDirect self-pay: Zepbound vials, KwikPen tiers and the 45-day refill rule
How Lilly's self-pay program works as of September 4, 2026: the $299, $399 and $449 tiers for Zepbound single-dose vials and the multi-dose KwikPen, the regular prices that apply outside the 45-day window, what is and is not included, how the program has changed since 2024, and the Foundayo and Mounjaro self-pay routes.
Updated September 4, 2026
- 02
NovoCare Pharmacy self-pay: Wegovy and Ozempic prices, the $199 introduction and the subscription
How Novo Nordisk's self-pay channel works as of September 4, 2026: $199 for the first two fills then $349 for Wegovy and Ozempic pens, $399 for Wegovy HD, $499 for Ozempic 2 mg, $149 to $299 for the pills, the March 2026 prepaid subscription at $249 to $329, what a month means, and how the program evolved from $499.
Updated September 4, 2026
- 03
GLP-1 savings cards: floors, per-fill caps, annual caps and expiry dates
The manufacturer savings-card terms for Zepbound, Mounjaro, Wegovy, Ozempic, the Ozempic pill, Foundayo and Saxenda as of September 4, 2026, with worked examples of when the $25 headline holds and when the caps push you to $100 or more per fill.
Updated September 4, 2026
- 04
TrumpRx and the November 2025 pricing agreement: what changed for GLP-1 prices
What the November 6, 2025 agreements between the U.S. government, Lilly and Novo Nordisk set: $245 per month to Medicare and Medicaid for injectable Zepbound, Mounjaro, Wegovy and Ozempic, a $350 average TrumpRx cash price trending down, $149 starting-dose pills, the $50 Medicare copay, and what TrumpRx.gov shows on September 4, 2026.
Updated September 4, 2026